Core Points - Heartflow, Inc. has priced its upsized initial public offering (IPO) of 16,666,667 shares at $19.00 per share, aiming for gross proceeds of approximately $316.7 million before expenses [1] - The company has granted underwriters a 30-day option to purchase an additional 2,500,000 shares at the IPO price [1] - Trading on the Nasdaq Global Select Market is set to begin on August 8, 2025, under the ticker symbol "HTFL," with the offering closing expected on August 11, 2025 [1] Company Overview - Heartflow is focused on transforming coronary artery disease (CAD) into a screenable, diagnosable, and manageable condition through its AI-driven platform, Heartflow One [5] - The platform includes features such as Roadmap™ Analysis, FFRCT Analysis, and Plaque Analysis, and is supported by the ACC/AHA Chest Pain Guideline [5] - Heartflow has assisted clinicians in managing over 400,000 patients globally, backed by more than 600 peer-reviewed publications [5]
Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering
Globenewswire·2025-08-08 00:27